Core Viewpoint - A lawsuit has been filed against The Bancorp, Inc. and certain senior executives for potential violations of federal securities laws, alleging misrepresentation of risks associated with its loan portfolio [1][2][4]. Company Overview - The Bancorp, Inc. is a financial holding company involved in institutional banking, commercial real estate bridge lending, small business lending, and commercial fleet leasing, with a focus on loans collateralized by apartment buildings [3]. Allegations and Legal Proceedings - The lawsuit claims that Bancorp misrepresented the risks of default or loss on its REBL loan portfolio and inadequately accounted for credit losses, indicating weaknesses in internal controls over financial reporting [4]. - Investors have until May 16, 2025, to seek appointment as lead plaintiffs in the case, which is pending in the U.S. District Court for the District of Delaware [2]. Stock Performance and Impact of News - Following a report from Culper Research on March 21, 2024, which highlighted the risks associated with Bancorp's REBL loans, the stock price fell over 10%, from $36.04 to $32.12 [5]. - On October 24, 2024, Bancorp reported a net income of $51.5 million, leading to a 14% decline in stock price from $54.96 to $47.01 due to increased credit losses [6]. - On March 4, 2025, Bancorp disclosed issues with its Annual Report for the fiscal year ended December 31, 2024, causing a 4.4% drop in stock price from $53.59 to $51.25 [7].

NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against BigBear.ai Holdings, Inc. (NYSE: BBAI) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in BigBear.ai, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/bigbearai-holdings-inc. Investors have until June 10, 2025, to ask the Court to be a ...

Core Viewpoint - Pomerantz LLP is investigating claims of potential securities fraud and unlawful business practices involving Humana Inc. following a lawsuit filed by the U.S. Department of Justice alleging illegal kickbacks related to Medicare Advantage plans [1][3]. Group 1: Investigation and Legal Actions - Pomerantz LLP is representing investors of Humana Inc. in an investigation concerning possible securities fraud or unlawful business practices by the company and its officers [1]. - The U.S. Department of Justice filed a False Claims Act complaint against Humana and other health insurance companies, alleging that from 2016 to 2021, they paid hundreds of millions of dollars in illegal kickbacks to brokers for enrollments in Medicare Advantage plans [3]. - Following the DOJ's lawsuit announcement, Humana's stock price decreased by $6.20 per share, or 2.36%, closing at $256.04 on May 1, 2025 [3]. Group 2: Company Background - Pomerantz LLP is recognized as a leading firm in corporate, securities, and antitrust class litigation, with a history of over 85 years in fighting for victims of securities fraud and corporate misconduct [4].

NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Amerant Bancorp Inc. (“Amerant” or the “Company”) (NYSE: AMTB).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Amerant and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.  [Click here for information about joining the class action] On April 23, ...

LOS ANGELES, May 8, 2025 /PRNewswire/ -- The DJS Law Group announces that it is investigating claims on behalf of investors of Lantheus Holdings, Inc. ("Lantheus" or "the Company") (NASDAQ: LNTH) for violations of the securities laws. DJS Law Group INVESTIGATION DETAILS: The investigation focuses on whether the Company issued misleading statements and/or failed to disclose information pertinent to investors. Lantheus reported its financial results for the first quarter of 2025 on May 7, 2025. Along wit ...

BOSTON, May 08, 2025 (GLOBE NEWSWIRE) -- Block & Leviton is investigating Compass Diversified Holdings (NYSE: CODI) for potential securities law violations. Investors who have lost money in their Compass Diversified Holdings investment should contact the firm to learn more about how they might recover those losses. For more details, visit https://blockleviton.com/cases/codi. What is this all about? Shares of Compass Diversified Holdings fell over 60% in intraday trading on May 8, 2025, following the company ...

NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Perpetua Resources Corp. ("Perpetua Resources Corp." or the "Company") (NASDAQ: PPTA) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Perpetua Resources Corp. investors who were adversely affected by alleged securities fraud between April 17, 2024 and February 13, 2025. Follow the link below to get more information and be contacted by a member of our team: https://z ...

NEW YORK, May 07, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Solaris Energy Infrastructure, Inc. (NYSE: SEI). Shareholders who purchased shares of SEI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/solaris-energy-infrastructure-inc-loss-submission-form/?id=147132&f ...

NEW YORK, May 07, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Avis Budget Group, Inc. (NASDAQ: CAR). Shareholders who purchased shares of CAR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/avis-budget-loss-submission-form/?id=147119&from=3 CLASS PERIOD: February 16, ...

Core Viewpoint - Treace Medical Concepts, Inc. is facing a class action lawsuit due to allegations of issuing materially false and misleading statements regarding its primary product, the 3D bunion correction system, "Lapiplasty" [3]. Summary by Relevant Sections Company Performance - The lawsuit claims that competition negatively affected the demand and utilization of Treace Medical's primary product, leading to a decline in revenue [3]. - The company was required to expedite plans for an alternative product to osteotomy due to the declining performance of its existing offerings [3]. Legal Proceedings - The class period for the lawsuit is defined as May 8, 2023, to May 7, 2024 [3]. - Shareholders who purchased shares during this period are encouraged to register for participation in the class action, with a deadline set for June 10, 2025 [4]. Investor Information - The Gross Law Firm is representing the shareholders and aims to protect the rights of investors who have suffered losses due to the alleged misleading statements by Treace Medical [5]. - Registered shareholders will receive updates through a portfolio monitoring software throughout the lifecycle of the case [4].